|Title of host publication||Encyclopedia of Pharmacy Practice and Clinical Pharmacy|
|Editors||Zaheer Ud-Din Babar|
|Number of pages||7|
|Publication status||Published - 20 Jun 2019|
Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.
Hasan, S. S., Kow, C. S., & Babar, Z-U-D. (2019). High-Cost Medicines: Access, Affordability, and Prices. In Z. U-D. Babar (Ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy (1 ed., Vol. 2, pp. 20-26). Elsevier.